5 notable Series B financing efforts from 2014 – Philadelphia Business Journal
Philadelphia Business Journal5 notable Series B financing efforts from 2014Philadelphia Business JournalThe Series B venture capital financing followed the company's completion of a phase-II clinical trial that yielded positive results for its lead product candidate, A-101, which is being developed as treatment for a common type of skin tumor known as …
[monetize id=”1″]
[monetize id=”2″]
Vanda Pharmaceuticals Announces Tradipitant Phase II Proof of Concept Study Results for Chronic Pruritus in Atopic …
WASHINGTON, March 4, 2015 /PRNewswire/ — Vanda Pharmaceuticals Inc. (Vanda) (NASDAQ: VNDA) today announced top-line results of the Phase II proof of concept clinical study investigating the safety and …